Sun Pharma: Speciality pipeline gets a boost

Sun Pharmaceutical industries has signed a definitive agreement to acquire 100% of U.S.-based Concert Pharma at $8 per share, i.e., $576 million to access the company’s experimental drug for treating patchy baldness. As per the agreement, Concert shareholders will also get non-tradeable contingent value right worth $3.5 per share i.e $252million. The acquisition gives Sun […]

Sebi proposes corporate governance norms for high value debt listed entity

Capital markets regulator Sebi on Wednesday proposed corporate governance norms pertaining to Related Party Transactions (RPTs) for a high-value debt-listed entity, with an outstanding value of listed non-convertible debt securities of at least Rs 500 crore. In its consultation paper, the Securities and Exchange Board of India (Sebi) has suggested the need to review the […]

网站备案号: 粤ICP备16118000号-1